IGF1R and Alzheimer disease: IGF-I signaling is also markedly disturbed in the brain of patients with Alzheimer’s Disease (AD; Frölich et al., 1998, 1999; Moloney et al., 2010) with alterations in both the levels and phosphorylation state of IGF-I receptor (IGF-IR) as well as the levels and distribution of IGF-I and IGF-IR mRNA in the brain (Rivera et al., 2005; Steen et al., 2005).